NON-CONTROLLING INTEREST |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Noncontrolling Interest [Abstract] | |
| NON-CONTROLLING INTEREST | NOTE 14 – NON-CONTROLLING INTEREST
On August 19, 2024, the minority shareholders in Pharmalectin, which included Company officers, exercised a conversion option for a 16.8% ownership in Bioxytran. The outstanding non-controlling interest of $855,160 was eliminated against equity.
|